The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Foster Wayne since 2018.
This trader's CIK number is 1709769.
At the time of last reporting, Foster Wayne was the EVP, Chief Accounting Officer of Atea Pharmaceuticals, Inc.. (stock ticker symbol AVIR).
Also see all insider trading activities at Atea Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | AVIR | 0 | $0 | 12,477 | $47,899 | 33,334 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | MRSN | 0 | $0 | 0 | $0 | 14,705 | $52,320 |
1. Atea Pharmaceuticals, Inc. (AVIR)
2. Mersana Therapeutics, Inc. (MRSN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-01 | AVIR | Sale | 12,477 | 3.84 | 47,899 |
| 2024-01-31 | AVIR | Option Ex | 33,334 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-01-30 | MRSN | Option Ex | 14,705 | 3.56 | 52,320 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Foster Wayne (EVP, Chief Accounting Officer of Atea Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.